Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold shares to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On April 29, 2024, Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 2,686 shares of common stock at a price of $6.38 per share.
- The sale was to cover income tax withholding obligations related to the vesting of 9,071 restricted stock units (RSUs) on April 27, 2024.
- Following the transaction, Bergstrom beneficially owns 527,427 shares of Relay Therapeutics, including 472,496 shares underlying RSUs.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an executive's stock sale for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market, and are required by the SEC to ensure transparency of trading by corporate insiders.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial performance.
Key Dates
| Date | Description |
|---|---|
| 04/27/2024 | Vesting date of 9,071 restricted stock units (RSUs). |
| 04/29/2024 | Date of stock sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.